Vidyalakshmi Chandramohan

7PUBLICATIONS
24CO-AUTHORS
BiomaterialsEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 27, 2026
Anti-VEGF vascular remodeling drives germinal center B cell-rich tertiary lymphoid structures during antibody-toxin and anti-CD40 combination therapy in glioblastoma.

|Mar 20, 2024
Gene expression analysis suggests immunosuppressive roles of endolysosomes in glioblastoma.

Michael A Sun, Haipei Yao, Qing Yang

|Feb 08, 2023
Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models.

Scott Parker, Charlotte McDowall, Luis Sanchez-Perez

|May 31, 2019
Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations.

Vidyalakshmi Chandramohan, Xuhui Bao, Xin Yu

|Jan 10, 2019
Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors.

Xin Yu, Mikhail Dobrikov, Stephen T Keir

|Sep 22, 2017
Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs.

Michael C Brown, Eda K Holl, David Boczkowski

Pageof 2

Frequent Collaborators

2 joint publications

Darell D Bigner

2 joint publications

Smita K Nair

2 joint publications

David M Ashley

2 joint publications

Annick Desjardins